Warby Parker Inc. (WRBY)
NYSE: WRBY · Real-Time Price · USD
16.28
-0.34 (-2.05%)
May 9, 2025, 11:32 AM - Market open

Company Description

Warby Parker Inc. provides eyewear products in the United States and Canada.

The company offers eyeglasses, sunglasses, single-vision lenses, progressive lenses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses.

It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, travel cases, lenses cloth, anti-fog lens spray, and sun clip-ons through its retail stores, website, and mobile apps.

In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

Warby Parker Inc.
Warby Parker logo
Country United States
Founded 2010
IPO Date Sep 29, 2021
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 3,780
CEO Neil Harris Blumenthal

Contact Details

Address:
233 Spring Street, 6th Floor East
New York, New York 10013
United States
Phone 646 847 7215
Website warbyparker.com

Stock Details

Ticker Symbol WRBY
Exchange NYSE
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
IPO Price $40.00
CIK Code 0001504776
CUSIP Number 93403J106
ISIN Number US93403J1060
Employer ID 80-0423634
SIC Code 3851

Key Executives

Name Position
David Abraham Gilboa Co-Founder, Co-Chief Executive Officer and Co-Chair
Neil Harris Blumenthal Co-Founder, President, Co-Chief Executive Officer and Co-Chair
Jeff Raider Co-Founder and Independent Director
Steve Miller Senior Vice President, Chief Financial Officer and Treasurer
Andrew M. Hunt Co-Founder and Independent Director
Jeffrey Saunders Senior Vice President and Chief Technology Officer
Jaclyn Berkley Head of Investor Relations
Chris Utecht Senior Vice President, General Counsel and Secretary
Lori Krauss Senior Vice President and Chief Marketing Officer
Chelsea Kaden Senior Vice President and Chief People Officer

Latest SEC Filings

Date Type Title
May 8, 2025 10-Q Quarterly Report
May 8, 2025 8-K Current Report
May 7, 2025 SCHEDULE 13G/A Filing
May 6, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 28, 2025 ARS Filing
Apr 28, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 28, 2025 DEF 14A Other definitive proxy statements
Apr 17, 2025 SCHEDULE 13G/A Filing
Mar 4, 2025 144 Filing
Mar 4, 2025 144 Filing